The diagnosis of minimal hepatic encephalopathy (MHE) is more difficult in comparison to the diagnosis of overt hepatic encephalopathy (OHE), as patients with MHE do not exhibit overt neurological deficits and must be diagnosed using specialized equipment. However, identifying MHE is critical for patients with cirrhosis, and a simple screening test is required. The present study aimed to evaluate the associations between MHE, clinical characteristics and questionnaire items regarding sleep disturbances and cirrhosis-related symptom score (CSS). A total of 91 patients who had cirrhosis without OHE were evaluated using various questionnaires [i.e., CSS, Epworth Sleepiness Scale, the Japanese version of the Pittsburgh Sleep Quality Index (PSQI) and the Japanese 36-item short-form health survey (SF-36)]. MHE was diagnosed using the neuropsychological test. MHE was associated with severe liver damage, which was indicated by liver damage markers and a history of OHE. In addition, MHE was associated with the CSS, PSQI and SF-36 results. The multivariate analyses revealed that a history of OHE was the factor that was the most strongly associated with MHE. Among patients without a history of OHE, MHE was most strongly associated with CSS, although it was also associated with severe liver damage and platelet counts. A prediction score (calculated using a history of OHE and CSS) provided an area under the receiver operating characteristic curve of 0.738 and a sensitivity of 0.671 for identifying MHE. In conclusion, a history of OHE and CSS may be useful for identifying MHE in patients with cirrhosis.
Introduction
Hepatic encephalopathy (HE) is a severe complication among patients with cirrhosis, as it is associated with poor survival outcomes and a reduced quality of life (1) . The diagnosis of overt HE (OHE) is relatively simple, as patients exhibit reduced consciousness and neurological deficits, and treatment can typically be started at the onset of the symptoms. However, minimal HE (MHE) is much more difficult to diagnose, as patients with MHE do not exhibit overt neurological deficits, and sensitive psychometric tests are required to diagnose these patients. The recent guidelines regarding the clinical management of MHE encourage the use of these tests (2) , although they require large amounts of time and specialized equipment. For example, the diagnosis of MHE in Japan is typically performed using a personal computer with a specific touch panel (3) . Other studies have reported that magnetic resonance spectroscopy (4), neuroelectrical latency (5) and critical flicker frequency (6) can be used to diagnose MHE, although these techniques are also limited by their requirement for specialized equipment. Serum levels of nitrotyrosine (7) and inflammatory cytokines (8) may also be useful for diagnosing MHE, although these techniques are not commercially available in Japan. However, it is critical to diagnose MHE in patients with cirrhosis, as MHE is a risk factor for OHE (9) , reduces the 5-year survival rate for cirrhosis (10) , impairs the ability of an individual to drive a vehicle (11) , increases the incidence of motor vehicle accidents (12, 13) and increases the risk of falls (14) . Furthermore, MHE is a highly prevalent cognitive disorder that severely affects the health-related quality of life for individuals (15) . Additionally, MHE was diagnosed in 30.1% of cirrhotic patients in Japan (16) . It shows that MHE is not a rare condition in liver cirrhosis. Therefore, a simple and effective screening method is urgently needed to identify patients with MHE.
Our previous study reported that sleep disturbances in patients with cirrhosis are mainly caused by restless legs syndrome (RLS) (17) , and that Child-Pugh scores (CPS) are associated with cirrhosis-related symptom scores (CSS), which are calculated using questionnaire items that were developed in our previous study (18) . Furthermore, sleep disturbances and RLS could be accurately diagnosed using this questionnaire and the sleep disturbances in patients without OHE improved following consuming a branched-chain amino acid (BCAA)-enriched snack (18) . Moreover, our previous study reported that patients who underwent living donor liver transplantation also experienced sleep disturbances, which were caused by RLS, sleep apnea syndrome and MHE (19) . Among these patients, the Japanese 36-item short-form health survey (SF-36) scores were associated with MHE (20) , which was diagnosed using a two-dimensional operation system (3) . Therefore, the present study aimed to evaluate the associations between MHE, clinical parameters and questionnaire item scores for sleep disturbances, RLS and CSS.
Patients and methods
Patients. The present study evaluated 91 patients (41 women and 50 men) with cirrhosis who were being evaluated for liver transplantation at Nagasaki University Hospital (Nagasaki, Japan) between July 2011 and May 2014. All the patients had liver cirrhosis, which was diagnosed using laboratory data and imaging findings. None of the patients had OHE at their initial evaluation, and any OHE was subsequently diagnosed using clinical findings.
Diagnosis of MHE.
The neuropsychological test (NPT) system is designed to assess psychomotor, attention, memory and special functions in order to diagnose MHE. This system consists of eight tests: Number connection tests A and B, a figure position test, a digit symbol test, a block design test and reaction time tests A-C. The system was simplified to accommodate two-dimensional manipulation using a computer and all tests can be completed in ~20 min, which includes the time that is required for practice and reading the operation guide. The software for this system was developed by Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan), Kokuyo Co., Ltd. (Osaka, Japan) and ISB Co., Ltd. (Tokyo, Japan).
Clinical and laboratory parameters. All the patients underwent anthropometric measurements to calculate body mass index (kg/m 2 ). Laboratory testing was also performed to obtain data regarding the following parameters: White blood cells, red blood cells, platelets (PLT), prothrombin time, blood urea nitrogen, creatinine, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transpeptidase, alkaline phosphatase, total bilirubin, total protein, albumin (ALB), high-density lipoprotein, low-density lipoprotein, cholinesterase (ChE), triglycerides, fasting blood glucose and ammonia. Each patient was questioned regarding whether they had a history of OHE, variceal bleeding, ascites or oral Questionnaires. The CSS questionnaire contained items regarding cirrhotic symptoms, which included hand tremors, appetite loss, foot muscle cramps, fatigue, decreased strength, anxiety, abdominal fullness, abdominal pain, a feeling of low energy, difficulty falling asleep, sleeping poorly and being sleepy during the daytime. An 'impact factor' for each item was calculated, which was defined as the product of the frequency of the item and the mean importance that the patients attributed to the item. The impact factor for each item ranged from 0 to 3, and the CSS was calculated as the sum of the impact factors (18 (Table IV) . When the associations between MHE and the CSS items were examined, patients with MHE exhibited significantly higher scores for hand tremors, appetite loss and decreased strength, as well as non-significant increases in the scores for fatigue and anxiety (verses the normal patients) (Table V) . However, no significant differences were observed when we compared the scores for muscle cramping, abdominal fullness, abdominal pain, a feeling of low energy and the three sleep-related items.
Predicting MHE. Based on these results, the factors that may predict MHE were evaluated. A history of OHE was the best marker for predicting MHE (odds ratio, 9.014), and CSS was the best marker for predicting MHE in patients without a history of OHE (odds ratio, 1.187). Therefore, a prediction score was developed that combined a history of OHE (no: 0 points, yes: 10 points) and CSS (range, 0-36 points), and evaluated its ability to predict MHE using receiver operating characteristic curve analysis (Fig. 1) . The area under the curve was 0.738 and the cut-off value was 8.97. Based on a cut-off score of 9 points, the prediction score provided a sensitivity of 0.671 and a specificity of 0.333 for MHE.
Discussion
In the present study, patients were evaluated for signs of MHE, which was indicated by severe liver damage, MELD score, CPS and a history of OHE. In addition, the CSS, PSQI scores and SF-36 items were associated with MHE. The multivariate analyses revealed that a history of OHE was the best predictor of MHE. However, among patients without a history of OHE, MHE was associated with indicators of severe liver damage, such as CPS, MELD score and platelet counts, and CSS was the best predictor of MHE among those patients. Furthermore, a novel prediction score was developed for MHE using a history of OHE and CSS, which provided an area under the curve of 0.738 and a sensitivity of 0.671. Similar to these findings, it has been reported that patients with MHE exhibit severe liver damage (as indicated by a high MELD score) (10, 24, 25) and high CPS (24) . However, the previous studies did not include patients with a history of OHE (23, 24) . Moreover, OHE and MHE are not fully treated via liver transplantation (19, 26) , and patients with a history of OHE may experience impaired cognitive function, even subsequent to resolving the OHE (27) . Therefore, patients with resolved OHE may be at risk for developing MHE, regardless of the extent of any liver damage. Furthermore, MHE is a risk factor for OHE (9) , and resolution of OHE is a risk factor for MHE, which highlights the importance of accurately determining whether patients with cirrhosis have a history of OHE. The present findings confirm this concept, as a history of OHE was the best predictor of MHE among all the variables that were evaluated.
It is well known that BCAA affects MHE and OHE (16), there were a few patients with a history of OHE who had already treated with BCAA in this study. Therefore, the MHE group had a significantly higher number of patients who were treated with BCAA supplements compared to the normal group. Thus, there was a possibility of the effects that BCAA supplements improve OHE to MHE.
Patients without a history of OHE were also evaluated, and as speculated, their sleep disturbances may be associated with MHE. Notably, low PSQI scores and frequent RLS were associated with MHE among patients with a history of OHE, although these associations were not observed among patients without a history of OHE. Furthermore, CSS was the best predictor of MHE among the patients without a history of OHE. In this context, CSS is calculated using items from a cirrhosis symptom questionnaire that was developed in our previous study, and three of the 12 items in this tool are associated with sleep disturbances. Moreover, our previous study reported that CSS, excluding the scores for the three sleep disturbance-related items, is associated with liver damage (18) . In the present study, three CSS items (hand tremors, appetite loss and decreased strength) were significantly associated with MHE, and these associations validate the previously reported associations between MHE and the following responses: 'I do not maintain balance', 'I act irritable or impatient with myself', 'I am not doing any of my usual physical recreations or activity' and 'I am eating much less than usual' (25) . Another study has also reported that worry was strongly associated with MHE in a questionnaire regarding chronic liver disease (24) . Although the majority of the patients with MHE experience symptoms that contribute to cognitive impairment, their other limitations (such as hand tremors, appetite loss and decreased strength) may also reflect restrictions in their activities of daily living. By contrast, MHE was not associated with difficulty in falling asleep, sleeping poorly and being sleepy during the daytime, which would indicate that patients with MHE, but not OHE, do not experience sleep disturbances.
In conclusion, the present findings indicate that a history of OHE was the best predictor of MHE, and CSS was the best predictor of MHE among patients without a history of OHE. Therefore, a prediction score was developed using a history of OHE and CSS, and this score appears to be effective in screening for MHE among patients with cirrhosis. However, this score is not highly specific for MHE, and additional parameters are required to develop a more sensitive screening tool. As patients with cirrhosis have multiple symptoms, which may be associated with cognitive impairment (28) , the incorporation of cognitive impairment symptoms into the present prediction score may increase its sensitivity for MHE. 
